Find and Pitch Jounalists, Get Your Story Covered

Tags: Software & Services Software Platforms IT Automation Apple cell biology, Craniofacial, developmental biology, DNA repair, genetics, oxidative stress

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 8 days ago STAT+: FDA agrees to review a rare disease drug that its developer was about to give up on - 6 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 9 months ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	3 FDA approval dates to watch in the year’s final push - 9 days ago Autobahn’s road to a breakthrough depression treatment is paved with high-profile investors - about 1 month ago In a Duchenne market beset by problems, Capricor data marks a bright spot - about 2 months ago To overcome barriers, cell and gene therapies need outside support - 2 months ago The hunt for the brain’s biomarkers - 3 months ago FDA’s platform designation aims to ease R&D pain points - 3 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 4 months ago As AI proliferates in pharma, regulators look to catch up in clinical trials - 5 months ago Black Diamond looks to outwit cancer mutations - 7 months ago For Moderna, COVID vaccines were a ‘proof of concept’ — now comes the big test - 7 months ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: U.K. charities give $36 million to start new drugs for childhood tumors - 15 days ago
4	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Is anyone taking the world’s priciest drugs? - 21 days ago Neuro drugs are still faltering, despite rising investment - about 2 months ago Up-and-comers look for an edge in the bustling ADC field - 3 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 4 months ago Where competition is heating up in pharma - 4 months ago After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era - 4 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - 6 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 8 months ago PharmaVoice 100s: Clinical trial gurus - 11 months ago 3 recent FDA adcomm rejections — and why they matter - 12 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 28 days ago Key Market Trends for the Current Specialty Drug Pipeline - 11 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines - about 2 months ago Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials - 5 months ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund - 2 months ago
8	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA finalizes guidance on studying opioid use disorder treatments - 2 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 3 months ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Testing drugs on mini-cancers in the lab may reveal best treatment - 5 months ago

Journalists covering drug development